Luxem\u00adbourg \u2014 Vector Inno\u00adva\u00adtion Fund GP S.\u00e0.r.l. (VIF) has now laun\u00adched an expec\u00adted $300 million pande\u00admic protec\u00adtion sub-fund 1. This first sub-fund aims to invest in tech\u00adno\u00adlo\u00adgies for pande\u00admic protec\u00adtion and future health\u00adcare, aiding and support\u00ading precis\u00adion medi\u00adcine, highly advan\u00adced point of care and AI tech\u00adno\u00adlo\u00adgies to support the global economy, sustainable health\u00adcare, and life longe\u00advity. This first sub-fund\u2019s objec\u00adtive is to target commit\u00adments total\u00adling $300m due to a strong deal flow, with an expec\u00adted first close of $120m and a final close expec\u00adted within 19 months.<\/p>\n
The Gene\u00adral Part\u00adners have an excel\u00adlent track record in indus\u00adtry, health\u00adcare, tech\u00adno\u00adlogy and invest\u00adment, with 21 exits and a total value crea\u00adtion of $2.4billion, inclu\u00adding two successful IPOs.<\/p>\n
VIF is a Reser\u00adved Alter\u00adna\u00adtive Invest\u00adment Fund based in Luxem\u00adbourg has just been incor\u00adpo\u00adra\u00adted under the laws of the Grand Duchy of Luxem\u00adbourg as a corpo\u00adrate part\u00adner\u00adship limi\u00adted by shares (soci\u00e9t\u00e9 en comman\u00addite par actions) quali\u00adfy\u00ading as an invest\u00adment company with varia\u00adble capi\u00adtal \u2014 reser\u00adved alter\u00adna\u00adtive invest\u00adment fund (soci\u00e9t\u00e9 d\u2019in\u00adves\u00adtis\u00adse\u00adment \u00e0 capi\u00adtal varia\u00adble \u2014 fonds d\u2019in\u00adves\u00adtis\u00adse\u00adment alter\u00adna\u00adtif r\u00e9serv\u00e9) under the RAIF Law.<\/p>\n
VIF has been set up as an umbrella struc\u00adture with sub-fund Vector Inno\u00adva\u00adtion Fund \u2014 Pande\u00admic Protec\u00adtion Fund 1 at incor\u00adpo\u00adra\u00adtion date. The Gene\u00adral Part\u00adner might, at its discre\u00adtion, launch addi\u00adtio\u00adnal sub-funds (which may be open-ended or close-ended) each of which is repre\u00adsen\u00adted by one or more Clas\u00adses of Shares. The fund quali\u00adfies as an AIF within the meaning of the AIFM Law.<\/p>\n
Each sub-fund shall consti\u00adtute a distinct and segre\u00adga\u00adted part of the assets and liabi\u00adli\u00adties of VIF\u2019s umbrella structure.<\/p>\n
Econo\u00admic fore\u00adcas\u00adters say fall\u00adout from COVID-19 is driving huge invest\u00adment within AI and nano\u00adtech\u00adno\u00adlogy as health\u00adcare invest\u00adment is expec\u00adted to grow at a rate of nearly 50% extra a year toward a market set to be worth $1.333 tril\u00adlion by 2027, accor\u00adding to Prece\u00addence Rese\u00adarch 2020.<\/p>\n
The Pande\u00admic Protec\u00adtion sub-fund 1 plans to invest in sophisti\u00adca\u00adted biotech and nano\u00adtech\u00adno\u00adlogy-based diagno\u00adstics, biomar\u00adkers, vacci\u00adnes, novel thera\u00adpies, highly targe\u00adted nano\u00adme\u00addi\u00adci\u00adnes, and AI, allo\u00adwing us to move to a more sustainable, digi\u00adti\u00adsed, decen\u00adtra\u00adli\u00adsed and demo\u00adcra\u00adtised point-of-care envi\u00adron\u00adment. The world cannot afford another pande\u00admic, the ongo\u00ading impact of long Covid symptoms will have a profound effect on health\u00adcare provi\u00adsion for the next five to ten years. The world of invest\u00adment, indus\u00adtry and govern\u00adments are gearing up to be better prepared and are funding future proof tech\u00adno\u00adlo\u00adgies for global health.<\/p>\n
These dyna\u00admic invest\u00adments will help to poten\u00adti\u00adally free up our econo\u00admies and future-proof us from infec\u00adtious dise\u00ada\u00adses as well as deve\u00adlop solu\u00adti\u00adons to anti\u00adbio\u00adtic resis\u00adtance, another global health\u00adcare chall\u00adenge that only tech\u00adno\u00adlogy can solve.<\/p>\n
VIF, repre\u00adsen\u00adted by its mana\u00adging gene\u00adral part\u00adner Vector Inno\u00adva\u00adtion GP, has also appoin\u00adted Fuchs Asset Manage\u00adment S.A., led by CEO Timo\u00adthe Fuchs. Fuchs Asset Manage\u00adment S.A. is a public limi\u00adted liabi\u00adlity company based in Luxem\u00adbourg, as the quali\u00adfied Fund Mana\u00adger (AIFM) gover\u00adned under Luxem\u00adbourg law for reser\u00adved alter\u00adna\u00adtive invest\u00adment funds under RAIF Law 2016.<\/p>\n
The appoin\u00adted invest\u00adment advi\u00adsor for the fund is Enab\u00adling Tech Invest\u00adment Advi\u00adsors S.\u00c0 R.L. who is also based and incor\u00adpo\u00adra\u00adted in Luxem\u00adbourg under Luxem\u00adbourg law. VIF\u2019s depo\u00adsi\u00adtory bank is Banque de Luxem\u00adbourg. Other inter\u00adna\u00adtio\u00adnal service provi\u00adders include Mait\u00adland, Ashurst, The World Nano Foun\u00adda\u00adtion and World Science Aid.<\/p>\n
The fund has brought toge\u00adther some of the worl\u00add\u2019s leading figu\u00adres in biome\u00addi\u00adcine, advan\u00adced diagno\u00adstics, nano biomar\u00adkers, tele\u00adme\u00addi\u00adcine, AI and machine lear\u00adning to acce\u00adle\u00adrate these trans\u00adfor\u00adma\u00adtio\u00adnal tech\u00adno\u00adlo\u00adgies into the markets, backed by sophisti\u00adca\u00adted, UHNW and insti\u00adtu\u00adtio\u00adnal inves\u00adtors crea\u00adting poten\u00adti\u00adally one of the most dyna\u00admic inter\u00adna\u00adtio\u00adnal invest\u00adment structures.<\/p>\n
VIF\u2019s fund invest\u00adment stra\u00adtegy looks to deli\u00adver 25\u201330% esti\u00adma\u00adted gross IRR, 4x MOIC over the life of the fund with an esti\u00admate of 10\u201312 diver\u00adsi\u00adfied invest\u00adments per sub-fund.<\/p>\n
Each pros\u00adpect company seeking invest\u00adment from VIF must demons\u00adtrate to our invest\u00adment advi\u00adsors, our global advi\u00adsory board, invest\u00adment commit\u00adtee and fund mana\u00adgers, their ability to commer\u00adcia\u00adlise highly disrup\u00adtive tech\u00adno\u00adlogy globally. For this, VIF uses its unique proprie\u00adtary rating system for stra\u00adtegy imple\u00admen\u00adta\u00adtion, using world-class bench\u00admark mode\u00adling for tech\u00adno\u00adlogy and health\u00adcare investment.<\/p>\n
The Fund\u2019s Enab\u00adling Tech\u00adno\u00adlogy Invest\u00adment Advi\u00adsors and global advi\u00adsory board are inter\u00adna\u00adtio\u00adnal leaders in these fields of exper\u00adtise. This has been demons\u00adtra\u00adted via previous start ups that have gone on to become \u2018unicorns\u2019, as well as our team\u2019s wider expe\u00adri\u00adence with large conglo\u00adme\u00adra\u00adtes in terms of advi\u00adsing and support\u00ading them on stra\u00adtegy, scaling or commer\u00adcia\u00adli\u00adsing disrup\u00adtive inno\u00adva\u00adtions in inter\u00adna\u00adtio\u00adnal markets.<\/p>\n
One inter\u00adna\u00adtio\u00adnal invest\u00adment plat\u00adform is a Pande\u00admic Protec\u00adtion alter\u00adna\u00adtive invest\u00adment fund opera\u00adted by Vector Inno\u00adva\u00adtion Fund in Luxem\u00adbourg focu\u00adsed on limi\u00adting the effect of long form Covid-19, insu\u00adla\u00adting the world against the impact of future pande\u00admics, whilst mini\u00admi\u00adsing any impact on the global economy and health\u00adcare provi\u00adsion and prepared\u00adness. As well as this, the fund is commit\u00adted to enhan\u00adcing the deve\u00adlo\u00adp\u00adment and preva\u00adlence of nano\u00adtech\u00adno\u00adlogy in healthcare.<\/p>\n
The Vector Inno\u00adva\u00adtion Fund is a Reser\u00adved Alter\u00adna\u00adtive Invest\u00adment Fund (RAIF) specia\u00adli\u00adsing in support for tech\u00adno\u00adlogy compa\u00adnies able to trans\u00adform global markets, nota\u00adbly in global health\u00adcare, sustaina\u00adbi\u00adlity and longe\u00advity. These trans\u00adfor\u00adma\u00adtio\u00adnal tech\u00adno\u00adlo\u00adgies come from the nano\u00adtech\u00adno\u00adlogy, biotech, AI and machine lear\u00adning, medi\u00adcal devices, thera\u00adpies and digi\u00adtal health sectors.<\/p>\n
The Vector Inno\u00adva\u00adtion Fund (VIF) is a semi-regu\u00adla\u00adted alter\u00adna\u00adtive invest\u00adment fund based in Luxem\u00adbourg and offers all the bene\u00adfits a sophisti\u00adca\u00adted or accre\u00addi\u00adted inter\u00adna\u00adtio\u00adnal inves\u00adtor would require and has seve\u00adral sub-funds: Pande\u00admic Protec\u00adtion Fund, Enab\u00adling Tech\u00adno\u00adlo\u00adgies Fund, Future Health\u00adcare Fund.<\/p>\n
The VIF was incor\u00adpo\u00adra\u00adted on Novem\u00adber 30th, 2020 for its first sub fund for Pande\u00admic Protec\u00adtion Fund and Future Health\u00adcare. www.vectorinnovationfund.com<\/p>\n","protected":false},"excerpt":{"rendered":"
Luxem\u00adbourg \u2014 Vector Inno\u00adva\u00adtion Fund GP S.\u00e0.r.l. (VIF) has now laun\u00adched an expec\u00adted $300 million pande\u00admic protec\u00adtion sub-fund 1. This first sub-fund aims to invest in tech\u00adno\u00adlo\u00adgies for pande\u00admic protec\u00adtion and future health\u00adcare, aiding and support\u00ading precis\u00adion medi\u00adcine, highly advan\u00adced point of care and AI tech\u00adno\u00adlo\u00adgies to support the global economy, sustainable health\u00adcare, and life [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":36611,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1368,1369,1373,1386],"tags":[],"class_list":["post-43356","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-lawyers-tax-consultants-auditors","category-investors","category-venture-capital-en","category-capital-market-advisor","news-category-deals-news-en"],"yoast_head":"\n